Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Krystal Biotech (KRYS) Assets Average (2021 - 2025)

Krystal Biotech (KRYS) has disclosed Assets Average for 5 consecutive years, with $1.3 billion as the latest value for Q4 2025.

  • Quarterly Assets Average rose 26.29% to $1.3 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.3 billion through Dec 2025, up 26.29% year-over-year, with the annual reading at $1.2 billion for FY2025, 27.5% up from the prior year.
  • Assets Average hit $1.3 billion in Q4 2025 for Krystal Biotech, up from $1.2 billion in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $1.3 billion in Q4 2025 to a low of $443.3 million in Q2 2021.
  • Historically, Assets Average has averaged $781.5 million across 5 years, with a median of $737.2 million in 2023.
  • Biggest five-year swings in Assets Average: dropped 12.3% in 2023 and later surged 53.32% in 2024.
  • Year by year, Assets Average stood at $538.7 million in 2021, then increased by 5.33% to $567.4 million in 2022, then surged by 41.76% to $804.4 million in 2023, then rose by 26.7% to $1.0 billion in 2024, then grew by 26.29% to $1.3 billion in 2025.
  • Business Quant data shows Assets Average for KRYS at $1.3 billion in Q4 2025, $1.2 billion in Q3 2025, and $1.1 billion in Q2 2025.